Literature DB >> 626116

Cerebrospinal fluid lysozyme in bacterial and viral meningitis.

M Klockars, S Reitamo, T Weber, Y Kerttula.   

Abstract

The concentration of lysozyme (LZM) in cerebrospinal fluid was determined in 25 patients with bacterial meningitis, in 18 patients with viral meningitis and in 25 control patients who had other fibrile illnesses. The concentration of LZM was less than 1.5 microgram/ml in all control patients, and slightly to markedly raised in 10 patients with viral meningitis and in 11 out of 13 patients with untreated bacterial meningitis. The concentration of LZM was significantly different in the viral and bacterial meningitis patients (p less than 0.001). Most raised concentrations of cerebrospinal fluid LZM persisted for at least one week after the start of antibiotic treatment. The concentrations of LZM correlated well with concentrations of lactic dehydrogenase. These results show that the determination of cerebrospinal fluid LZM is a useful tool in the differential diagnosis of meningitis, particularly when the prehospital treatment with antibiotics may be responsible for a diagnostically misleading negative bacterial culture of the cerebrospinal fluid and altered cerebrospinal fluid cytology.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626116     DOI: 10.1111/j.0954-6820.1978.tb14834.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  11 in total

1.  Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae.

Authors:  Waldemar Vollmer; Alexander Tomasz
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Detection of lysozyme magnetic relaxation switches based on aptamer-functionalized superparamagnetic nanoparticles.

Authors:  Suwussa Bamrungsap; Mohammed Ibrahim Shukoor; Tao Chen; Kwame Sefah; Weihong Tan
Journal:  Anal Chem       Date:  2011-09-22       Impact factor: 6.986

3.  Identification of some main Streptococcus iniae associated proteins: relationship.

Authors:  Fatima El Aamri; José Ángel Guillén; Daniel Padilla; Belinda Vega; Félix Acosta; Fernando Real
Journal:  Vet Res Commun       Date:  2017-01-14       Impact factor: 2.459

4.  Newer diagnostic techniques in microbial infections.

Authors:  A Ansari; R Nachum
Journal:  Indian J Pediatr       Date:  1982 Nov-Dec       Impact factor: 1.967

5.  The differential diagnosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests.

Authors:  A Pönkä; K Ojala; A M Teppo; T H Weber
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

6.  Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid.

Authors:  A Severin; E Severina; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

7.  Rapid differentiation of bacterial meningitides by direct gas-liquid chromatography.

Authors:  H Thadepalli; P K Gangopadhyay; A Ansari; G D Overturf; V K Dhawan; A K Mandal
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Use of selective capture of transcribed sequences to identify genes preferentially expressed by Streptococcus suis upon interaction with porcine brain microvascular endothelial cells.

Authors:  Nahuel Fittipaldi; Marcelo Gottschalk; Ghyslaine Vanier; France Daigle; Josée Harel
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

9.  Role of the cathelicidin-related antimicrobial peptide in inflammation and mortality in a mouse model of bacterial meningitis.

Authors:  Julika Merres; Jonas Höss; Lea-Jessica Albrecht; Eugenia Kress; Oliver Soehnlein; Sandra Jansen; Thomas Pufe; Simone C Tauber; Lars-Ove Brandenburg
Journal:  J Innate Immun       Date:  2013-08-22       Impact factor: 7.349

10.  Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation.

Authors:  R Hällgren; A Terént; P Venge
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.